Cancer Drug Development with Drs. A. Adjei and W. Cance

Sunday, January 29, 2012
 
00:00

Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and Chair of the Department of Medicine, and William Cance, MD, RPCI Surgeon-in-Chief and Co-Founder of CureFAKtor Pharmaceuticals LLC, discuss trends in cancer pharmacotherapy at RPCI and worldwide. They also address the concerning drug shortages that have affected cancer patients nationwide.